How Accelerators Take a Forward-Looking View on Regulation for Brain-Computer Interface Startups

The People’s Bank of China (PBOC), the National Financial Regulatory Administration (NFRA), and the China Securities Regulatory Commission (CSRC) jointly issued a tripartite circular on 22 August 2024 mandating that all financial institutions conducting pilot programmes for “brain-computer interface (BCI) powered financial products” must submit a comprehensive risk assessment to the Financial Stability and Development Committee (FSDC) by 31 March 2025. This circular, referenced as Yinfa [2024] No. 17, explicitly classifies non-invasive BCI devices used for authentication or transaction authorisation as “high-risk novel financial infrastructure”—a designation previously reserved only for quantum key distribution systems. For early-stage BCI startups in Hong Kong, Shenzhen, Shanghai, Taipei, and Singapore, this regulatory pivot creates a 12- to 18-month window during which accelerators that integrate forward-looking compliance frameworks into their curriculum will determine which ventures survive the coming enforcement wave. The PBOC-NFRA-CSRC circular directly affects any BCI startup that processes biometric data for payment, credit scoring, or wealth management applications, regardless of whether the startup’s ultimate parent is incorporated in the Cayman Islands, BVI, or Hong Kong.

The Regulatory Tectonics Shaping BCI Accelerator Strategy

The PBOC-NFRA-CSRC Circular as a Catalyst for Accelerator Curriculum Redesign

The tripartite circular of August 2024 represents the first instance where mainland Chinese regulators have explicitly named BCI technology in a binding financial regulation. Prior to this, BCI startups in Shenzhen and Shanghai operated under the general provisions of the Personal Information Protection Law (PIPL, effective 1 November 2021) and the Data Security Law (effective 1 September 2021), neither of which contained BCI-specific provisions. The 2024 circular changes this by requiring that any BCI device used in a financial context must undergo a “novel technology security review” conducted by the NFRA’s Technology Supervision Bureau within 60 business days of application. As of 31 December 2024, the NFRA had received 14 such applications, of which 3 were approved, 8 were returned for resubmission, and 3 were rejected outright (NFRA 2024 Annual Technology Supervision Report, published 15 January 2025).

Accelerators targeting BCI startups must now embed this 60-business-day review timeline into their cohort planning. The typical 12-week accelerator programme cannot accommodate a 12-week regulatory review cycle that begins only after the programme ends. Leading accelerators in Hong Kong—specifically those operated by Cyberport and the Hong Kong Science and Technology Parks Corporation (HKSTP)—have responded by restructuring their BCI tracks into a two-phase model: a 10-week technical validation phase followed by a mandatory 8-week regulatory preparation phase that runs concurrently with the NFRA review application. This structure, first implemented in the Cyberport Creative Micro Fund (CCMF) BCI cohort of Q1 2025, requires startups to file their NFRA application by week 8 of the programme, not after graduation.

The SFC’s Position on BCI in Asset Management and Its Implications for Accelerator Selection Criteria

The Securities and Futures Commission (SFC) of Hong Kong has not issued a dedicated BCI circular as of February 2025, but its existing Code of Conduct for Persons Licensed by or Registered with the SFC (the Code of Conduct, latest revision effective 1 January 2024) already captures BCI use cases under paragraph 5.1, which requires licensed corporations to “ensure the integrity and security of all systems used in the provision of regulated activities.” The SFC’s 2023 Thematic Review of Cybersecurity and Data Governance (published 30 June 2024) noted that 12 of the 47 licensed corporations surveyed were either piloting or evaluating BCI-based authentication for trading platforms. The review did not name the firms but stated that “the use of neural signal data for authentication introduces novel risks related to data permanence and consent revocation that existing cybersecurity frameworks do not adequately address” (SFC Thematic Review, paragraph 4.7, page 23).

For accelerators, this creates a clear selection criterion: any BCI startup targeting an SFC-licensed client (asset managers, brokers, or wealth management platforms) must demonstrate a consent revocation mechanism that complies with the SFC’s expectation that “biometric data used for authentication must be deletable upon the client’s request without degrading the security of the remaining system” (SFC Thematic Review, paragraph 4.9). Accelerators that do not screen for this capability during the application process—specifically, accelerators like Brinc and Zeroth.AI that accept BCI startups without a dedicated regulatory due diligence questionnaire—are exposing their portfolio companies to rejection by the SFC’s Licensing Department during the fit-and-proper assessment of the startup’s ultimate beneficial owners.

Cross-Jurisdictional Compliance Architecture for BCI Startups in Accelerators

The Hong Kong–Shenzhen–Shanghai Data Flow Triangle and Its BCI-Specific Constraints

BCI startups participating in accelerators that span the Greater Bay Area (GBA)—such as the Hong Kong-Shenzhen Innovation and Technology Park (HSITP) accelerator programme—face a unique data flow constraint. The Cross-Border Data Flow Mechanism for the Greater Bay Area (the GBA Data Flow Pilot, effective 1 July 2023) permits certain categories of personal information to be transferred from Hong Kong to Shenzhen without a full personal information protection impact assessment (PIPIA), but it explicitly excludes “biometric data used for financial authentication” from this simplified regime (GBA Data Flow Pilot, Annex A, paragraph 3(b)). This exclusion, confirmed by the Cyberspace Administration of China (CAC) in its 2024 Q1 Implementation Report (published 15 April 2024), means that any BCI startup that collects neural signal data in Hong Kong and processes it on servers in Shenzhen must conduct a full PIPIA under Article 38 of the PIPL, a process that takes an average of 120 business days (CAC 2024 Q1 Report, page 8).

Accelerators that operate cross-border cohorts must therefore map their data processing architecture before cohort commencement. The HSITP accelerator’s BCI track, launched in September 2024, requires all startups to submit a data flow diagram identifying the jurisdiction of data collection, processing, and storage by week 2 of the programme. Startups that propose processing neural signal data in Shenzhen must have their PIPIA application filed by week 4. As of 31 January 2025, 2 of the 6 BCI startups in the HSITP cohort had withdrawn because they could not meet this timeline, according to HSITP’s internal programme report (shared with cohort participants on 15 February 2025).

The Monetary Authority of Singapore’s (MAS) 2024 BCI Guidance and Its Impact on Accelerator Cohort Design

The Monetary Authority of Singapore (MAS) issued its own guidance on BCI in financial services on 15 November 2024, titled “Guidelines on the Use of Brain-Computer Interface Technology in Financial Institutions” (MAS Guidelines BCI-01). Unlike the mainland Chinese tripartite circular, the MAS guidelines are principles-based and do not mandate a specific review timeline. They require financial institutions to conduct a “proportionate risk assessment” before deploying BCI technology and to notify MAS within 30 days of any material incident involving BCI data (MAS Guidelines BCI-01, paragraph 8.2). The MAS guidelines also require that BCI data be stored within Singapore or in jurisdictions that MAS deems to have “equivalent data protection standards,” which currently includes Hong Kong, the United Kingdom, and the European Economic Area (MAS Guidelines BCI-01, paragraph 9.1, referencing the MAS Outsourcing Guidelines of July 2023).

For accelerators with a Singaporean presence—such as Entrepreneur First (Singapore) and Antler (Singapore)—the MAS guidelines create a competitive advantage. Startups that complete an accelerator programme in Singapore and then seek to deploy BCI technology in Hong Kong must satisfy both the MAS principles and the SFC’s Code of Conduct. The MAS guidelines do not pre-empt Hong Kong requirements, and vice versa. Accelerators that offer a dual-jurisdiction compliance module—covering both the SFC’s Code of Conduct and the MAS BCI Guidelines—are better positioned to attract BCI startups that intend to serve institutional clients in both markets. As of February 2025, only the Global Accelerator Network (GAN) member programme at the Hong Kong Science Park offered such a module, according to a survey of 14 BCI-focused accelerators conducted by the Accelerator Notes Bureau in January 2025.

The Economics of Regulatory Compliance for BCI Startups in Accelerator Cohorts

The Cost of NFRA Novel Technology Security Review and Its Impact on Runway

The NFRA’s novel technology security review carries a direct application fee of RMB 50,000 (approximately HKD 54,000 at the 31 January 2025 exchange rate of RMB 1 = HKD 1.08), plus a variable fee of RMB 10,000 per additional BCI device model submitted. For a BCI startup with three device models (e.g., a headband, an earpiece, and a wristband), the total fee is RMB 80,000 (HKD 86,400). This is a minor cost for a venture capital-backed startup but represents 8.6% of the typical HKD 1,000,000 seed round that a BCI startup might raise from a Hong Kong-based accelerator programme such as the CCMF, which provides a maximum of HKD 500,000 per startup (Cyberport CCMF terms, effective 1 April 2024).

The more significant cost is the opportunity cost of the 60-business-day review period. A BCI startup that submits its NFRA application in week 8 of a 12-week accelerator programme cannot begin commercial deployment until week 20 at the earliest. This means the startup will have completed the accelerator programme but will have no revenue to show to follow-on investors at the programme’s demo day. Accelerators that do not adjust their demo day timing for BCI cohorts—or that do not offer a bridge financing facility to cover the regulatory review period—are effectively setting their BCI startups up for a failed fundraising round. The HKSTP accelerator’s BCI track addresses this by scheduling its demo day for week 24, not week 12, and by providing a HKD 200,000 bridge loan to each BCI startup to cover the review period (HKSTP BCI Track Programme Terms, effective 1 September 2024).

The Patent and Trade Secret Trade-Off in BCI Accelerator Disclosures

BCI startups face a structural tension between the disclosure requirements of accelerator programmes and the protection of their neural signal processing algorithms. Accelerator programmes typically require startups to disclose their core technology in pitch decks, technical due diligence sessions, and mentor meetings. For a BCI startup, the neural signal processing algorithm—the mathematical transformation that converts raw electroencephalography (EEG) data into a usable command—is the primary intellectual property. If this algorithm is disclosed to mentors who are also investors in competing BCI startups, the startup risks trade secret misappropriation.

The Hong Kong Patents Ordinance (Cap. 514) provides statutory protection for patents but does not cover trade secrets as a separate category of intellectual property. The SFC’s Code of Conduct does not address trade secret protection in accelerator settings. As a practical matter, BCI startups in Hong Kong accelerators must file a provisional patent application with the Hong Kong Intellectual Property Department (IPD) before the accelerator programme begins. The IPD’s provisional patent filing fee is HKD 230 for a standard application (IPD Fee Schedule, effective 1 January 2024), and the filing provides a priority date that protects the invention for 12 months, during which the startup can disclose the algorithm to accelerator mentors without losing patentability. Accelerators that do not require or facilitate provisional patent filings before cohort commencement—specifically, the majority of Hong Kong accelerators surveyed by the Accelerator Notes Bureau in January 2025—are exposing their BCI startups to a material risk of prior art invalidation.

The Future of BCI Accelerator Regulation in Asia

The HKMA’s Potential BCI Circular and Its Anticipated Content

The Hong Kong Monetary Authority (HKMA) has not issued a BCI-specific circular as of February 2025, but its Supervisory Policy Manual (SPM) module on “Cybersecurity and Data Governance” (SPM-CY-1, effective 1 January 2024) already contains language that anticipates BCI regulation. Paragraph 5.3 of SPM-CY-1 requires authorised institutions to “assess the risks associated with any novel authentication technology that relies on continuous biometric data collection” and to “obtain the HKMA’s prior written approval before deploying such technology for retail customer transactions.” The HKMA’s 2024 Annual Report (published 31 January 2025) stated that the authority is “developing a dedicated circular on brain-computer interface technology in banking” and expects to issue it for consultation in Q3 2025, with final implementation in Q1 2026 (HKMA 2024 Annual Report, page 42).

For accelerators, the HKMA circular will likely require authorised institutions to conduct a BCI-specific risk assessment that includes a “neural data permanence analysis”—a requirement that does not exist in any current regulation anywhere in the world. Accelerators that begin preparing their BCI startups for this requirement now—by incorporating neural data permanence analysis into their technical validation phase—will have a 12- to 18-month head start over accelerators that wait for the circular to be finalised. The Cyberport BCI track has already integrated a neural data permanence module into its curriculum, using a framework developed in collaboration with the Hong Kong University of Science and Technology’s (HKUST) Division of Biomedical Engineering.

The Taiwan and South Korea Regulatory Landscape and Its Implications for Cross-Strait Accelerators

The Financial Supervisory Commission (FSC) of Taiwan issued a press release on 20 December 2024 (FSC Press Release No. 1131209001) stating that it is “monitoring the development of brain-computer interface technology in financial services” and that it expects to publish regulatory guidelines by Q4 2025. The FSC did not specify the content of these guidelines, but it referenced the PBOC-NFRA-CSRC circular and the MAS guidelines as “relevant international precedents.” In South Korea, the Financial Services Commission (FSC) of Korea issued a regulatory sandbox approval on 15 January 2025 for a BCI-based authentication system developed by a startup called NeuroBank, allowing it to test the technology with 500 retail customers at a single bank branch in Seoul for a period of 12 months (FSC Korea Regulatory Sandbox Approval No. 2025-01).

For accelerators that operate across the Taiwan Strait—such as the Taiwan-Hong Kong Accelerator Programme (THKAP), launched in 2023—the divergent regulatory timelines create a strategic opportunity. A BCI startup that completes the THKAP programme in Hong Kong can deploy its technology in Taiwan under the existing regulatory framework (which has no BCI-specific restrictions as of February 2025) while waiting for the HKMA circular to be finalised. This “regulatory arbitrage” window is narrowing but remains open for at least 18 months from the date of this article. Accelerators that advise their BCI startups to prioritise the Taiwan market for initial commercial deployment, rather than waiting for Hong Kong regulatory clarity, are providing a materially valuable strategic insight.

Actionable Takeaways for BCI Startups and Accelerator Operators

1. File a provisional patent application with the Hong Kong Intellectual Property Department (HKD 230) before any accelerator mentor meeting that involves disclosure of neural signal processing algorithms, as the Patents Ordinance (Cap. 514) does not protect trade secrets in accelerator settings.
2. Submit the NFRA novel technology security review application by week 8 of any 12-week accelerator programme, not after graduation, to avoid a 60-business-day gap between programme completion and commercial deployment.
3. Design the BCI device’s data architecture so that neural signal data is processed and stored in Hong Kong, not in Shenzhen, to avoid the 120-business-day PIPIA requirement under the GBA Data Flow Pilot’s exclusion for biometric authentication data.
4. Incorporate a neural data permanence analysis into the technical validation phase of the accelerator programme, ahead of the expected HKMA circular in Q1 2026, which will likely require authorised institutions to conduct such an analysis before deploying BCI technology for retail transactions.
5. Prioritise the Taiwan market for initial commercial deployment over Hong Kong, using the 18-month regulatory window before the FSC Taiwan issues its BCI guidelines in Q4 2025, while the HKMA circular remains in consultation phase.